Assessment of adverse events related to anti-influenza neuraminidase inhibitors using the FDA adverse event reporting system and online patient reviews
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-60068-5
Abstract: The recommended antiviral drugs available for the treatment and prevention of influenza are neuraminidase inhibitors (NAIs). The aim of this study was to evaluate age-related clinical manifestations of adverse events (AEs) related to NAIs. FAERS… read more here.
Keywords: reporting; adverse events; assessment adverse; influenza neuraminidase ... See more keywords
[Development and Evaluation of the Questionnaire for the Assessment of Adverse and Protective Childhood Experiences (APC)].
Sign Up to like & getrecommendations! Published in 2020 at "Psychiatrische Praxis"
DOI: 10.1055/a-1123-1615
Abstract: OBJECTIVE Aim of this study is to evaluate the newly developed Questionnaire for the Assessment of Adverse and Protective Childhood Experiences (APC). METHODS Reliability, convergent as well as criterion validity were assessed in a sample… read more here.
Keywords: childhood; protective childhood; questionnaire assessment; assessment adverse ... See more keywords
T45. THE NEW YORK ASSESSMENT OF ADVERSE COGNITIVE EFFECTS OF NEUROPSYCHIATRIC TREATMENT (NY-AACENT): INITIAL VALIDATION FINDINGS
Sign Up to like & getrecommendations! Published in 2019 at "Schizophrenia Bulletin"
DOI: 10.1093/schbul/sbz019.325
Abstract: BACKGROUND Adverse cognitive side effects of medications impact the functioning of patients with schizophrenia. There is a lack of scales that focus on drug-induced effects on cognition, particularly in adolescents with schizophrenia. The New York… read more here.
Keywords: assessment adverse; cognitive effects; effects neuropsychiatric; new york ... See more keywords